All In Biotech

Free tool

FAERS Monitor: Matulane

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016785 or its brand name (Matulane, Procarbazine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,792

Serious

1,270

27% of reports

Hospitalization

593

Death reported

323

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,054
  • fatigue934
  • vomiting327
  • constipation296
  • platelet count decreased257
  • white blood cell count decreased244
  • headache198
  • decreased appetite194
  • rash173
  • diarrhoea147
  • neutropenia147
  • blood count abnormal132
  • thrombocytopenia125
  • dizziness119
  • urticaria113

Reports by year received

View as table
YearReports
20047
20054
20062
20077
20085
20095
201045
2011136
2012250
201371
201455
2015201
2016245
2017592
2018555
2019348
2020318
2021233
2022355
2023344
2024358
2025345
2026311

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,367 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood count abnormalSignal13238.532.64,752
platelet count decreasedSignal25710.69.42,232
white blood cell count decreasedSignal2449.98.81,949
constipationSignal2966.05.31,229
nauseaSignal1,0545.95.54,395
fatigueSignal9345.35.03,348
thrombocytopeniaSignal1254.94.1387
neutropeniaSignal1474.74.1434
decreased appetiteSignal1943.73.2378
vomitingSignal3273.12.8460
urticariaSignal1133.02.5146
rash1731.71.555
headache1981.41.222
dizziness1191.00.90
diarrhoea1471.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.